CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 22 No. 6
 

Remembering Martin D. Abeloff, MD

By Cara H. Glynn
Andrew Nash | May 1, 2008

Dr. Martin D. AbeloffIt is an honor to present our readers with this special commemorative issue prepared in tribute to the life and career of Dr. Martin D. Abeloff, co-Editor-in-Chief of ONCOLOGY from 1999 to 2007.

 “Marty was one of the most decent and thoughtful leaders in our field,” said a colleague. This was just one of countless heartfelt sentiments made by Dr. Abeloff’s colleagues and friends on learning of his death from leukemia this past September 2007.

The scope of loss posed by his untimely death is difficult to comprehend. It is inspirational, however, to experience through the recollections of those who knew him best how profoundly Marty’s life impacted so many as physician, teacher, and mentor. It is these sentiments and more that we hope to share throughout the pages of this special issue.

Compiling this commemorative edition to honor Dr. Abeloff was a bittersweet though positive and rewarding experience, and the word “privilege” repeatedly comes to mind. How very fortunate we were to know and work with Marty on ONCOLOGY. It is certainly our privilege to honor his memory.

The reviews and essays herein comprise an important desk reference on breast cancer and discuss milestones and turning points in the treatment of early and advanced disease; the psychosocial effect of the disease on patients; and what’s on the horizon in regard to breast cancer prevention. Importantly, however, it is our hope that this commemorative issue will provide readers with key insights into the compelling cancer research, important clinical advances, and tremendous accomplishments that occurred over the past 35 years during Marty’s career, and the important role he played in so many of these critical changes in patient care.

We thank the contributors and advisors who so graciously assisted in the development of this comprehensive resource and so willingly shared their unique and personal reflections on this remarkable man. To Dr. Abeloff’s family, and to his many colleagues and friends at the Sidney Kimmel Comprehensive Cancer Center, and in the oncology community, we extend our deepest regret and sympathy.

With Marty’s inspiring career in mind, we also look forward to continuing ONCOLOGY’s mission—presenting practical clinical information for oncologists—confident that so much of the work he pioneered will lead to further improvements in care for patients with cancer.

—Cara H. Glynn
—Andrew Nash

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

THE MARTIN D. ABELOFF SCHOLARS PROGRAM IN CANCER PREVENTION AND CONTROL

A gift opportunity presented by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins to honor Martin D. Abeloff, MD

The Martin D. Abeloff Scholars Program addresses the capacity building needs for cancer prevention and control by training and supporting outstanding mature investigators and mentors, and by training young scientists, whose impact on this field will be felt for the rest of the century. To make a donation and support this program, contact the Development Officers at http://www.hopkinskimmelcancercenter.org/kpr/abeloff-scholars-program.cfm

Or Contact: Johns Hopkins Kimmel Cancer Center, One Charles Center,
100 North Charles Street, Suite 234, Baltimore, MD 21201
Phone (410) 516-4203; Fax (410) 230-4262

Milestones and Memories

What follows are highlights of Dr. Abeloff’s life and career, interspersed with quotes from the man himself.

1942 Martin D. Abeloff born in Schuylkill County, Pennsylvania.

1954 His mother undergoes a radical mastectomy for breast cancer, influencing his decision to become a doctor and specialize in the care of patients with cancer.

“You can’t simply treat cancer without paying attention to the psychological and social aspects of the disease… [T]herapies have been lengthy, toxic, and disfiguring adding to the amount of suffering that a patient and family endures.”

***

1961 Enrolls at Johns Hopkins School of Medicine where he works with researcher Dr. Albert Owens.

1967 Marries Diane Kaufman, a medical illustrator and his wife of 40 years; performs his internship and residency training at the University of Chicago, the Baltimore Cancer Research Center, and the Beth Israel Hospital. He subsequently completes a hematology fellowship at New England Medical Center.

1972 Joins Johns Hopkins faculty and sees his first breast cancer patient.

“There was an urgency about this disease that demanded a merging of laboratory and clinic. In many ways cancer became the impetus for translational medicine as we know it today.”

***

1973 Becomes a member of the first class of board-certified medical oncologists in the United States.

1984–1988 Serves as chair of the Oncology Drug Advisory Committee of the US Food and Drug Administration.

1992–2007 Becomes the second Director of the Johns Hopkins Cancer Center, succeeding Albert Owens. During his 15-year tenure as Director the number of faculty doubled, research funding was increased sixfold, and the cancer center was consistently ranked among the top three cancer centers in the United States. During this time he also established the “Art of Healing” program, a performing arts series and a collection of more than 100 works of museum quality art displayed at the institution for the enjoyment of patients, visitors, and staff.

“There is no doubt that the accomplishments of the past 15 years are remarkable and worth discussion. But I see them not as my accomplishments but as those of the amazing faculty and staff I have had the privilege to lead over these years.”

***

2001 Sidney Kimmel, founder and chairman of Jones Apparel Group, donates $150 million to Johns Hopkins for cancer research and patient care—the largest single gift ever to the University. The Hopkins Cancer Center officially becomes The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

“Sidney Kimmel has shown enormous vision and insight into what would make a difference in the field of cancer research, as well as great confidence in our ability to achieve results. We are truly honored by this gift.”

***

“While it was important to build facilities that gave people the space, equipment, and environment they needed to be successful, it was just as important to build teams. Together, we knocked down boundaries—those physical and those in our minds—to create a truly comprehensive center bringing together every discipline involved in the research and treatment of cancer.”

***

2007 Receives ASCO’s Distinguished Service Award for Scientific Achievement for his leadership in the field of translational breast cancer research.

***

September 14, 2007 Dr. Martin D. Abeloff succumbs to death from leukemia.

***

“What has been most satisfying to me has been the opportunity to participate in patient care”

—Martin D. Abeloff






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • Skin Lesions
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy